Aspirin Dose and Prevention of Coronary Abnormalities in Kawasaki Disease

Acetylsalicylic acid (ASA) is part of the recommended treatment of Kawasaki disease (KD). Controversies remain regarding the optimal dose of ASA to be used. We aimed to evaluate the noninferiority of ASA at an antiplatelet dose in acute KD in preventing coronary artery (CA) abnormalities.This is a m...

詳細記述

保存先:
書誌詳細
主要な著者: Frédéric Dallaire, Zoe Fortier-Morissette, Samuel Blais, Anita Dhanrajani, Dania Basodan, Claudia Renaud, Mathew Mathew, Astrid M. De Souza, Audrey Dionne, Joël Blanchard, Harrison Saulnier, Kimberley Kaspy, Soha Rached-d’Astous, Nagib Dahdah, Brian W. McCrindle, Derek G. Human, Rosie Scuccimarri
フォーマット: Artigo
言語:英語
出版事項: 2017
オンライン・アクセス:https://doi.org/10.1542/peds.2017-0098
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!